Bioventus is entering the patient care market in Taiwan with the launch of DUROLANE.
Here are five highlights:
1. DUROLANE is a single-injection joint-fluid osteoarthritis treatment based on a natural, safe and proven technology process called NASHA, which yields stabilizing hyaluronic acid.
2. Hyaluronic acid is a naturally occurring molecule that provides the lubrication and cushioning in a normal joint.
3. In Taiwan, DUROLANE is indicated for the treatment of mild to moderate osteoarthritis of the knee.
4. In Taiwan, Bioventus will be working with Eulogiums, a sales and marketing leader with more than 20 years of experience in orthopedics.
5. Bioventus is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely.